Vaccinations for the Holy Month

Since January 2022, booster vaccines have been available in Indonesia[1], which increased positive sentiment both in the market[2] and for the public in general. To date, more than 70% of Indonesians have been vaccinated twice and the number of booster recipients have been increasing steadily[3]. Especially with booster vaccines making it easier for people who want to go back to their hometowns during Ramadan and/or Eid-al-Fitr[4], we ask respondents on how the current festivities affect their sentiments regarding vaccinations.


With the increased positive sentiment, we can see that 88% respondents have already made plans for social gatherings during Ramadan and/or Eid-al-Fitr. But what does it mean in regards to vaccination levels? We asked two different groups. For those who haven’t completed their vaccinations yet (at minimum 2x), unfortunately only 52% are motivated to complete their vaccinations due to the coming festivities. And even when we ask the ones who have already completed their vaccinations and have gotten or are yet to get their booster doses, only 55% answered that the coming festivities are part of their motivation. 

Especially with the mass travel that comes with the upcoming Eid-al-Fitr, we need to remember that there is an ongoing target especially for primary vaccinations[5]. However, with the continuing decrease of active cases, we’ll continue to see if there will be any effect from vaccination levels towards the pandemic conditions in Indonesia.


[1] Kementerian Komunikasi dan Informatika Republik Indonesia – Pemerintah Putuskan Vaksinasi Booster Mulai 12 Januari Mendatang

[2] Bareksa – Bareksa Update : Vaksin Booster Jadi Sentimen Positif Pasar, Reksadana Ini Cemerlang

[3] Vaksinasi COVID-19 Nasional [Data per Tanggal 17 April 2022 Pukul 18.00 WIB]

[4] Kontan.co.id – Ini Syarat Mudik Lebaran 2022, Belum Vaksin Booster Bisa Lebaran di Kampung!

[5] Kompas.com – Kemenkes Targetkan Vaksinasi Covid-19 Selesai Akhir Maret 2022

Subscribe to Snapcart Reports

Get FREE data and insights sent to your inbox!